ÜREMİŞ, N. Et Al. 2022. Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK/STAT3, MAPK/ERK, and AKT/mTOR signaling pathways in HepG2 cell line. JOURNAL OF FOOD BIOCHEMISTRY , vol.46, no.10 .

ÜREMİŞ, N., ÜREMİŞ, M. M., ÇİĞREMİŞ, Y., TOSUN, E., BAYSAR, A., & TÜRKÖZ, Y., (2022). Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK/STAT3, MAPK/ERK, and AKT/mTOR signaling pathways in HepG2 cell line. JOURNAL OF FOOD BIOCHEMISTRY , vol.46, no.10.

ÜREMİŞ, NURAY Et Al. "Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK/STAT3, MAPK/ERK, and AKT/mTOR signaling pathways in HepG2 cell line," JOURNAL OF FOOD BIOCHEMISTRY , vol.46, no.10, 2022

ÜREMİŞ, NURAY Et Al. "Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK/STAT3, MAPK/ERK, and AKT/mTOR signaling pathways in HepG2 cell line." JOURNAL OF FOOD BIOCHEMISTRY , vol.46, no.10, 2022

ÜREMİŞ, N. Et Al. (2022) . "Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK/STAT3, MAPK/ERK, and AKT/mTOR signaling pathways in HepG2 cell line." JOURNAL OF FOOD BIOCHEMISTRY , vol.46, no.10.

@article{article, author={NURAY ÜREMİŞ Et Al. }, title={Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK/STAT3, MAPK/ERK, and AKT/mTOR signaling pathways in HepG2 cell line}, journal={JOURNAL OF FOOD BIOCHEMISTRY}, year=2022}